Full Text View
Tabular View
No Study Results Posted
Related Studies
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2009 by GlaxoSmithKline.
Recruitment status was  Active, not recruiting
Study NCT00742131   Information provided by GlaxoSmithKline

First Received on August 26, 2008.   Last Updated on April 23, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Solid Tumor Cancer
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
GSK1363089 (formerly XL880)
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services